Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease

Conference contribution


Publication Details

Author(s): Lapuerta P, Kulke MH, Pavel ME, Biran T, Fleming R, Zacks JS, Zacks JS, Hoffmanns P, Warner RRP
Publication year: 2018
Volume: 47
Journal issue: 3
Pages range: 345-345
ISSN: 0885-3177


FAU Authors / FAU Editors

Pavel, Marianne Ellen
Medizinische Klinik 1 - Gastroenterologie, Pneumologie und Endokrinologie


External institutions with authors

Dana–Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
Ipsen Pharma GmbH
Lexicon Pharmaceuticals, Inc.


How to cite

APA:
Lapuerta, P., Kulke, M.H., Pavel, M.E., Biran, T., Fleming, R., Zacks, J.S.,... Warner, R.R.P. (2018). Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease. (pp. 345-345).

MLA:
Lapuerta, Pablo, et al. "Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease." 2018. 345-345.

BibTeX: 

Last updated on 2019-24-01 at 08:38